hexyl 2,5-dichlorophenylphosphoroamidate has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Jiménez, S; Martínez-Salazar, F; Monroy-Noyola, A; Ríos, C; Trujillo, B; Vilanova, E; Yescas, P | 1 |
| Carrera, V; Quesada, E; Sabater, E; Sogorb, MA; Vilanova, E | 1 |
2 other study(ies) available for hexyl 2,5-dichlorophenylphosphoroamidate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Stereospecific hydrolysis of a phosphoramidate used as an OPIDP model by human sera with PON1 192 alloforms.
Topics: Adult; Aryldialkylphosphatase; Calcium; Female; Humans; Hydrolysis; Male; Middle Aged; Neurotoxicity Syndromes; Organophosphorus Compounds; Polymorphism, Genetic; Polyneuropathies; Stereoisomerism | 2015 |
Recovery of neuropathy target esterase activity after inhibition with mipafox and O-hexyl O-2,5-dichlorophenyl phosphoramidate in bovine chromaffin cell cultures.
Topics: Animals; Carboxylic Ester Hydrolases; Cattle; Cells, Cultured; Chromaffin Cells; Enzyme Inhibitors; Isoflurophate; Neurotoxicity Syndromes; Organophosphorus Compounds; Recovery of Function; Time Factors | 2007 |